Venture Studio
Building investible ventures from promising science and technology
D4 Bioventures supports early-stage life science and healthcare opportunities that are not yet ready for a traditional capital raise, licensing process or transaction.
These opportunities may have strong science or technology, but still need work to define the commercial opportunity, development path, IP position, business model, funding strategy, management requirements and route to market.
D4 helps shape these opportunities into credible venture propositions.
Venture Studio
At D4 Bioventures, we understand the challenges faced by Australian universities, medical research institutes and public sector agencies involved in commercialising early-stage technologies.
We can help identify the most promising commercial opportunities in your portfolio, help founder teams develop their technological innovations into market-led, commercially viable business propositions, and then raise investment into these ventures. Our investor network includes a range of alternative capital sources not typically accessible to technology commercialisation offices (e.g. family offices, HNWIs).
​
We also invest as principal in select projects, showcasing our belief in the projects we support.
Services
​
-
Opportunity Evaluation: Screening and prioritising commercialisation opportunities, identifying key next steps to become investor-ready, and advising on commercialization frameworks and incubation programs.
-
Venture Building – “Investor Readiness”: Validating market opportunities, sourcing management teams, developing business plans, connecting with industry partners, recommending transaction structuring options, and providing corporate governance advice.
-
Corporate Advisory and Capital Raising: Structuring deals, determining valuation and investment terms, identifying potential investors and/or partners, and advising on collateral material.
-
Transaction Execution: Executing transactions, negotiating terms, managing diligence and data rooms, and liaising with external consultants and legal counsel.
-
Post-transaction Deal Management: Monitoring and reviewing post-transaction activities and potential for ongoing Board or Advisory Board roles.
Why Teams Choose to Work with D4 Bioventures
Domain Expertise
Deep experience across biotech, medtech, diagnostics, and digital health, from technical assessment to commercial strategy.​
Investor Lens
We shape opportunities around the questions that investors, partners and acquirers will test.​​
​
​
Capital Access
We connect companies with relevant institutional, family office, HNWI and strategic investors across Australia and APAC, including Singapore and Hong Kong.
Deal Judgement
We understand how strategic value, risk, timing and negotiation shape successful transactions.
​
​
Outcome Focused
We focus on practical steps that add value by moving opportunities towards investment, partnering, licensing or exit.
​